Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
564.00    72.60 (14.77%)
Bid:
562.00
Ask:
563.00
Spread: 1.00 (0.178%)
Market Cap: £2.50b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

30 Jun 2017 15:36

Tate & Lyle PLC

Notification of transaction by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (‘Shares’) was made on 30 June 2017 under the Tate & Lyle Group Bonus Plan (‘GBP’) in respect of the year ended 31 March 2017 to Persons Discharging Managerial Responsibilities (‘PDMR’) as detailed in the table below:

PDMR No. of Shares
subject to award
Javed Ahmed (Chief Executive) 39,850
Nick Hampton (Chief Financial Officer) 40,739
Rowan Adams 19,345
Joan Braca 13,431
Robert Gibber 25,497
Rob Luijten 21,666
Pierre Schoumacher 4,168
Jim Stutelberg 31,426

No consideration is payable for the grant or exercise of the options or awards under the GBP. Further information on the operation of the GBP is provided in the Annual Report 2017.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’GradyCompany Secretary30 June 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Javed Ahmed
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 39,850

d) Aggregated
information

-- Aggregated volume

39,850

-- Price

Nil

e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Nick Hampton
2. Reason for the notification
a) Position / status PDMR – Chief Financial Officer
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 40,739

d) Aggregated
information
-- Aggregated volume 40,739
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive VP, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 19,345

d) Aggregated
information
-- Aggregated volume 19,345
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Joan Braca
2. Reason for the notification
a) Position / status PDMR - President, Speciality Food Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 13,431

d) Aggregated
information
-- Aggregated volume 13,431
-- Price Nil
e) Date of the transaction 2016-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Robert Gibber
2. Reason for the notification
a) Position / status PDMR – Executive VP, General Counsel
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 25,497

d) Aggregated
information
-- Aggregated volume 25,497
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Rob Luijten
2. Reason for the notification
a) Position / status PDMR – Executive VP, Human Resources
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 21,666

d) Aggregated
information
-- Aggregated volume 21,666
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Pierre Schoumacher
2. Reason for the notification
a) Position / status PDMR - President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 4,168

d) Aggregated
information
-- Aggregated volume 4,168
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR - President, Bulk Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 31,426

d) Aggregated
information
-- Aggregated volume 31,426
-- Price Nil
e) Date of the transaction 2017-06-30
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: http://www.businesswire.com/news/home/20170630005410/en/

Copyright Business Wire 2017

Date   Source Headline
8th Jun 20264:16 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend 1
8th Jun 20263:24 pmRNSForm 8.5 (EPT/RI)-Amend Tate & Lyle Plc
8th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
8th Jun 20263:18 pmRNSForm 8.3 Tate & Lyle Plc
8th Jun 20262:10 pmRNSForm 8.3 TATE & LYLE PLC
8th Jun 20261:06 pmRNSForm 8.3 - Tate & Lyle plc
8th Jun 202611:54 amRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
8th Jun 202611:38 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
8th Jun 202611:35 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
8th Jun 202611:30 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
8th Jun 202611:26 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
8th Jun 202610:42 amRNS20260605_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
8th Jun 202610:40 amRNS20260605_TATE & LYLE_8.5 EPT RI_UK_MLI
8th Jun 20269:18 amRNSForm 8.5 (EPT/RI)
8th Jun 20267:00 amRNSRecommended cash acquisition of Tate & Lyle PLC
5th Jun 20265:13 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
5th Jun 20263:21 pmRNSForm 8.3 - Tate & Lyle Plc
5th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
5th Jun 20262:47 pmRNSForm 8.3 - Tate & Lyle plc
5th Jun 20261:54 pmRNSForm 8.3 - Tate & Lyle plc
5th Jun 20261:49 pmRNSForm 8.3 Tate & Lyle Plc
5th Jun 202612:57 pmRNSForm 8.3 TATE & LYLE PLC
5th Jun 202612:04 pmRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
5th Jun 202612:00 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
5th Jun 202611:36 amRNS20260604_TATE & LYLE_8.5 EPT RI_UK_MLI
5th Jun 202611:29 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
5th Jun 202610:42 amRNSForm 8.3 - Tate & Lyle plc
5th Jun 20269:37 amRNSForm 8.5 (EPT/RI)
4th Jun 20263:26 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
4th Jun 20263:25 pmRNSForm 8.3 - TATE & LYLE PLC
4th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
4th Jun 20263:12 pmRNSForm 8.3 TATE & LYLE PLC
4th Jun 20262:45 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
4th Jun 20262:45 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
4th Jun 20262:25 pmRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle Plc
4th Jun 20262:23 pmRNSForm 8.3 - Tate & Lyle plc
4th Jun 20261:55 pmRNSForm 8.3 - Tate & Lyle plc
4th Jun 202612:57 pmRNSForm 8.3 - Tate & Lyle plc
4th Jun 202611:53 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
4th Jun 202611:32 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
4th Jun 202611:22 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
4th Jun 202611:19 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
4th Jun 202611:16 amRNS20260603_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
4th Jun 202611:14 amRNS20260603_TATE & LYLE_8.5 EPT RI_UK_MLI
4th Jun 202610:59 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
4th Jun 202610:40 amRNSForm 8.3 - Tate & Lyle PLC
4th Jun 20269:25 amRNSForm 8.5 (EPT/RI)
3rd Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jun 20263:16 pmRNSForm 8.3 TATE & LYLE PLC
3rd Jun 20262:25 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.